A Phase 2a Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of NT-0796 as an Adjunct to a Reduced Calorie Diet and Increased Physical Activity in Obese Participants With/Without Type 2 Diabetes over a 6 months treatment period.
A Phase 2a Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of NT-0796 as an Adjunct to a Reduced Calorie Diet and Increased Physical Activity in Obese Participants With/Without Type 2 Diabetes over a 6 months treatment period.
Evaluate the Efficacy and Safety of NT-0796 in Participants With Obesity With or Without Type 2 Diabetes Mellitus
-
Investigative site, Mesa, Arizona, United States, 85225
Investigative site, Los Angeles, California, United States, 90057
Investigative site, Cooper City, Florida, United States, 33024
New Generation of Medical Research, Hialeah, Florida, United States, 33016
Investigative Site, Jacksonville, Florida, United States, 32216
Investigative Sites, Marrero, Louisiana, United States, 70006
Investigative Site, Columbus, Ohio, United States, 43213
Investigative Site, Dallas, Texas, United States, 75230
Investigative Site, Manassas, Virginia, United States, 20110
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to 75 Years
ALL
No
NodThera Limited,
2026-03-31